Objective: To enhance the recognition of necrotizing sialometaplasia (NS) by elucidating its clinical, pathological characteristics and key diagnostic points, providing a basis for the diagnosis and treatment of the disease. Methods: This study has been reviewed and approved by the Medical Ethics Committee, and informed consent has been obtained from patients. Review the data of a patient with NS occurring at the junction of the right soft and hard palate, and comprehensively analyze its diagnostic process based on its clinical manifestations, imaging, and histopathological examination results. And review the relevant literature on the disease. Results: This study describes a 24-year-old male patient with a documented betel nut habit (2 pieces/day for >6 months), who presented with a bone-deep, irregular crateriform ulcer (3 mm × 6 mm × 5 mm) localized to the right hard-soft palate junction. Spiral CT showed a local soft tissue defect with no apparent underlying bone destruction. Histopathology demonstrated chronic inflammation of the mucosal and minor salivary gland tissues, with no evidence of malignancy. A final diagnosis of NS was established. The ulcer healed completely three weeks after initiation of local anti-inflammatory therapy. A literature review indicates that NS is a rare, benign salivary gland disorder, typically occurring at the hard-soft palate junction in middle-aged men (40-60 years). Its etiology remains unclear, but it is widely attributed to salivary lobe infarction following mechanical trauma-induced ischemia. Due to its clinical resemblance to malignancy, it is often misdiagnosed. Treatment entails local anti-inflammatory measures and meticulous wound care aimed at promoting mucosal healing. Conclusion NS is a self-limiting, benign condition that poses a significant diagnostic challenge due to its close clinical simulation of malignancy. Thus, accurate diagnosis requires a combined assessment of clinical presentation, radiological features, and pathological findings. Treatment is predicated based on a conservative strategy with an emphasis on symptomatic management.

Objective To analyze the current status,hotspots,and development trends of granulocyte-macrophage colony stimulating factor(GM-CSF)in immune-inflammatory response based on bibliometric analysis.Methods The Web of Science Core Collection database was utilized to retrieve relevant literatures from Jan.1,1990 to Jan.1,2024,and CiteSpace was applied to visualize and analyze the data.Results A total of 1219 GM-CSF in immunoinflammation related papers were included,and the number of publications was on the rise overall.The number of publications in the United States ranked the first in the world with 445 articles.The institution with the highest number was the University of Melbourne 25 articles.The authors tied for the first place were Jordana M and Becher B(10 articles for each),and the author with the highest citation count was Hamilton JA 128 times;the most cited journal was Journal of Immunology 986 times,and the high frequency keywords related to GM-CSF in immunoinflammation were mainly obtained on inflammation,dendritic cell,T cell,etc.The hotspots of research in recent years are focused on immunity and microglia.Conclusion The research of GM-CSF in immuno-inflammation continues to deepen,and its academic influence is gradually broadened.The future research direction lies in exploring the mechanism of GM-CSF in immunoinflammation and targeted therapy.